Hard Palate Melanoma: A Population-based Analysis of Epidemiology and Survival Outcomes.

Détails

ID Serval
serval:BIB_A28F5B9C9D5D
Type
Article: article d'un périodique ou d'un magazine.
Collection
Publications
Institution
Titre
Hard Palate Melanoma: A Population-based Analysis of Epidemiology and Survival Outcomes.
Périodique
Anticancer research
Auteur⸱e⸱s
Oranges C.M., Sisti G., Nasioudis D., Tremp M., DI Summa P.G., Kalbermatten D.F., Largo R.D., Schaefer D.J.
ISSN
1791-7530 (Electronic)
ISSN-L
0250-7005
Statut éditorial
Publié
Date de publication
10/2018
Peer-reviewed
Oui
Volume
38
Numéro
10
Pages
5811-5817
Langue
anglais
Notes
Publication types: Journal Article
Publication Status: ppublish
Résumé
Hard palate melanoma is an extremely rare and aggressive tumor arising from the mucosal epithelium of the oral cavity. The aim of this study was to analyze epidemiology, loco-regional treatment patterns and survival outcomes of this disease.
The National Cancer Institute's Surveillance Epidemiology and End Results (SEER) database was searched for all cases of hard palate melanoma diagnosed between 1973 and 2012. The Kaplan-Meier method was used to calculate overall survival rate, log-rank test to compare survivals of different subgroups, and Cox hazard regression analysis to determine independent predictors of overall survival.
Overall, 83 patients were identified, 49 female and 34 males. The distribution among ages was: 13.3% <50 years, 38.6% between 50 and 69 years, 48.2% ≥70. Surgery alone was applied in 48.2% of patients, radiation therapy alone in 6%, and combination of surgery and radiation therapy in 33.7%. Overall 5-year survival was 26.3%. Survival with adjuvant radiation therapy was not longer than with surgery alone.
Hard palate melanoma is a rare malignancy mostly affecting the elderly, with low overall survival. The main treatment is surgical resection, while adjuvant radiotherapy does not improve survival. The establishment of an international registry is warranted to better define treatment options.
Mots-clé
Adult, Aged, Aged, 80 and over, Antineoplastic Combined Chemotherapy Protocols/therapeutic use, Biomarkers, Tumor, Case-Control Studies, Combined Modality Therapy, Female, Follow-Up Studies, Humans, Lymphatic Metastasis, Male, Middle Aged, Neoplasm Invasiveness, Neoplasm Recurrence, Local/drug therapy, Neoplasm Recurrence, Local/pathology, Neoplasms/drug therapy, Neoplasms/pathology, Prognosis, Prospective Studies, Survival Rate, Head and neck cancer, SEER, hard palate, metastasis, mucosal melanoma, oral cancer, prognostic factors, survival rates, treatment
Pubmed
Web of science
Création de la notice
16/10/2018 15:44
Dernière modification de la notice
20/08/2019 16:08
Données d'usage